Viruses, Hepatology, Cancer

Share

Selected publications

Azoulay D, Audureau E, Bhangui P, Belghiti J, Boillot O, Andreani P, Castaing D, Cherqui D, Irtan S, Calmus Y, Chazouillères O, Soubrane O, Luciani A, Feray C. Living or Brain-dead Donor Liver Transplantation for Hepatocellular Carcinoma: A Multicenter, Western, Intent-to-treat Cohort Study.

Ann Surg. 2017 Dec;266(6):1035-1044.

CE Costentin, T Decaens, A Laurent, JC Nault, B Paule, C Letoublon, Alain Luciani, Julien Calderaro, R Adam, I Bricault, Giuliana Amaddeo, D Cherqui, A Mallat, D Samuel, C Duvoux, N Ganne-Carrie, F Roudot-Thoraval, E Vibert, Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysis

Liver Int. 01/12/2017;37(12) : 1869-1876 10.1111/liv.13491 13/07/2017

N De'Angelis, S Abdalla, V Lizzi, F Esposito, P Genova, L Roy, F Galacteros, Alain Luciani, F Brunetti, Incidence and predictors of portal and splenic vein thrombosis after pure laparoscopic splenectomy

Surgery. 01/12/2017;162(6) : 1219-1230 10.1016/j.surg.2017.07.016 14/09/2017

F Le Gal, Ségolène BRICHLER, T Drugan, C Alloui, D Roulot, Jean-Michel PAWLOTSKY, P Deny, Emmanuel GORDIEN, Genetic diversity and worldwide distribution of the deltavirus genus: A study of 2,152 clinical strains

Hepatology. 01/12/2017;66(6) : 1826-1841 10.1002/hep.29574. 30/10/2017

C Lim, H Shinkawa, K Hasegawa, P Bhangui, C Salloum, C Gomez Gavara, E Lahat, K Omichi, J Arita, Y Sakamoto, P Compagnon, Cyrille FERAY, N Kokudo, D Azoulay, Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysis

Liver Transpl. 01/12/2017;23(12) : 1553-1563 10.1002/lt.24952.

M Bazinet, V Pantea, V Cebotarescu, L Cojuhari, P Jimbei, JK Albrecht, P Schmid, F Le Gal, Emmanuel GORDIEN, A Krawczyk, H Mijocevic, H Karimzadeh, M Roggendorf, A Vaillant, Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial

Lancet Gastroenterol hepatol. 01/12/2017;2(12) : 877-889 10.1016/S2468-1253(17)30288-1. 28/09/2017

AD Marshall, EB Cunningham, S Nielsen, A Aghemo, H Alho, M Backmund, P Bruggmann, O Dalgard, C Seguin-Devaux, R Flisiak, GR Foster, L Gheorge, D Goldberg, I Goulis, M Hickman, P Hoffmann, L Janconriene, P Jarcuska, M Kaberg, LG Kostrikis, M Makara, M Maimets, RT Marinho, M Maticic, S Norris, S Olafsson, A Ovrehus, Jean-Michel PAWLOTSKY, J Pocock, G Robayes, C Roncero, M Simonova, J Sperl, M Tait, I Tolmane, S Tomaselli, M van der Valk, A Vince, GJ Dore, JV Lazarus, J Grebely, International Network on Hepatitis in Substance Users (INHSU), Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

Lancet Gastroenterol Hepatol. 27/11/2017;pii: S2468-1253(17) : 30284-4 0.1016/S2468-1253(17)30284-4. 27/11/2017

S Mule, F Pigneur, R Quelever, A Tenenhaus, L Baranes, P Richard, Vania TACHER, E Herin, H Pasquier, M Ronot, A Rahmouni, V Vilgrain, Alain LUCIANI, Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma?

Eur Radiol. 22/11/2017;. : . 10.1007/s00330-017-5151-y.

A Brown, Christophe HEZODE, E Zuckerman, GR Foster, A Zekry, SK Roberts, F Lahser, C Durkan, C Badshah, B Zhang, M Robertson, J Wahl, E Barr, B Haber, C-SCAPE Study Investigators, Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with HCV genotype 2, 4, 5, or 6 infection: the C-SCAPE study

J Viral Hepat. 20/11/2017;. : . 10.1111/jvh.12801

F Poordad, S Pol, A Asatryan, M Buti, D Shaw, Christophe HEZODE, F Felizarta, RW Reindollar, SC Gordon, S Pianko, MW Fried, D Bernstein, J Gallant, CW Lin, Y Lei, TI Ng, P Krishnan, S Kopecky-Bromberg, J Kort, FJ Mensa, Glecaprevir/Pibrentasvir in Patients with HCV Genotype 1 or 4 and Prior Direct-acting Antiviral Treatment Failure
Hepatology. 20/11/2017;. : . 10.1002/hep.29671

Hepatology. 20/11/2017;. : . 10.1002/hep.29671